Cytokinetics, Incorporated
IT ˙ BIT ˙ US23282W6057
62,32 € 0,00 (0,00%)
2026-06-03
DEL PRIS
SecurityIT:1CYTK / Cytokinetics, Incorporated
InstitutionXponance, Inc.
Latest Disclosed Ownership17,036 shares
Latest Disclosed Value $ 1,122,843
Xponance, Inc. reports 18.43% increase in ownership of 1CYTK / Cytokinetics, Incorporated

On May 13, 2026 - Xponance, Inc. filed a 13F-HR form disclosing ownership of 17,036 shares of Cytokinetics, Incorporated (IT:1CYTK) valued at $919,944 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 14,385 shares of Cytokinetics, Incorporated. This represents a change in shares of 18.43% during the quarter. The current value of the position is $1,061,684 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F CYTOKINETICS COM NEW 23282W605 17,036 2,651 18.43 1,123 22.76 0.0080
2026-02-12 2025-12-31 13F CYTOKINETICS COM NEW 23282W605 14,385 -2,328 -13.93 914 -0.44 0.0069
2025-11-12 2025-09-30 13F CYTOKINETICS COM NEW 23282W605 16,713 3 0.02 919 66.30 0.0073
2025-08-14 2025-06-30 13F CYTOKINETICS COM NEW 23282W605 16,710 149 0.90 552 -16.99 0.0046
2025-05-01 2025-03-31 13F CYTOKINETICS COM NEW 23282W605 16,561 33 0.20 666 -14.41 0.0064
2025-02-11 2024-12-31 13F CYTOKINETICS COM NEW 23282W605 16,528 853 5.44 777 -6.05 0.0071
2024-11-12 2024-09-30 13F CYTOKINETICS COM NEW 23282W605 15,675 473 3.11 828 0.49 0.0080
2024-08-14 2024-06-30 13F CYTOKINETICS COM NEW 23282W605 15,202 1,348 9.73 824 -15.24 0.0084
2024-05-13 2024-03-31 13F CYTOKINETICS COM NEW 23282W605 13,854 8,231 146.38 971 107.04 0.0102
2024-01-31 2023-12-31 13F CYTOKINETICS COM NEW 23282W605 5,623 5,623 469 0.0056
2023-04-18 2023-03-31 13F CYTOKINETICS COM NEW 23282W605 0 -4,699 -100.00 0 -100.00
2023-01-24 2022-12-31 13F CYTOKINETICS COM NEW 23282W605 4,699 73 1.58 215 -4.02 0.0035
2022-10-24 2022-09-30 13F CYTOKINETICS COM NEW 23282W605 4,626 4,626 224 0.0043
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.